Icahn School of Medicine at Mount Sinai | Institute for Translational Sciences
Established in 2009, the Icahn School of Medicine at Mount Sinai Clinical and Translational Science Award (CTSA) was renewed for a second five-year term in 2015 with a $34 million grant. The CTSA Program of the National Center for Advancing Translational Sciences (NCATS) mission is to accelerate discoveries, development, and delivery of new treatments to improve health outcomes across the lifespan. The mission of the ISMMS CTSA, ConduITS, is to streamline and centralize the infrastructure needed to accelerate translational research across an ever-expanding research enterprise; foster team science responsive to emerging theories, technologies, and data science challenges; innovate processes to increase the quality and efficiency of translational research; develop informatics tools and solutions to accelerate the full translational continuum, and develop innovative educational programs training the workforce needed to respond to the challenges of 21st Century translational science.